New Gene Therapies for Sickle Cell Anemia to be Considered by FDA

MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news